Sign in

Fluidra, S.A. FDR.MC

Price 18.9 EUR
as of 2026-09-05
54/100
Mixed
Quality58
Growth47
Balance-sheet strength54
Valuation70
Momentum27
Income80

Composite 54/100; the shares have moved about 27% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 27/100 — a moderate mark against it.

Case for

Income ranks 80/100 — a strong point in its favour. Valuation ranks 70/100 — a moderate point in its favour. Quality ranks 58/100 — a slight point in its favour.

Case against

Momentum ranks 27/100 — a moderate mark against it. Growth ranks 47/100 — a slight mark against it.

What the company does Fluidra designs, manufactures, and distributes pool equipment, water-treatment systems, and wellness products for residential and commercial markets globally.

Key financials Revenue grew 2.7% while EPS fell -4.0%. Margins: gross 55.7%, operating 13.6%, net 7.7%. ROE 10.6%, ROA 5.0%, ROCE 23.4%. Debt/equity 0.81, net debt/EBITDA 3.29, interest coverage 12.70.

Stock health Sideravia scores: Quality 59.4, Growth 42.8, Strength 56.1, Valuation 67.3, Momentum 30.8, Income 32.5. Piotroski F-Score 5/9, Altman Z 2.52. RSI(14) 58.50.

Price vs fair value The stock trades at a PREMIUM of 2.80% versus our fair-value estimate of 18.60 and at a discount of 36.24% versus the analyst 12-month target of 26.06. - Forward P/E 9.74 vs trailing 20.03 signals valuation support (Valuation 67.3). - Net margins 7.7% lag peers and may pressure premium (Quality 59.4). - Growth score 42.8% reflects muted revenue and EPS trends (Key financials). - Momentum percentile 30.8% indicates weak recent performance (Momentum 30.8).

Looking forward Analysts see 36.24% upside to 26.06, implying potential re-rating if growth accelerates and margins expand. Focus on execution in connected products and commercial segments to justify premium.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.